Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Frequency of Continuous Glucose Monitoring Use and Change in Hemoglobin A1C for Adults with Type 1 Diabetes in a Clinical Practice Setting.

McQueen RB, Ellis SL, Maahs DM, Anderson HD, Nair KV, Campbell JD.

Endocr Pract. 2014 Oct;20(10):1007-15. doi: 10.4158/EP14027.OR.


Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.


Continuous glucose monitoring for patients with diabetes: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2011;11(4):1-29. Epub 2011 Jul 1.


Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.

Poolsup N, Suksomboon N, Kyaw AM.

Diabetol Metab Syndr. 2013 Jul 23;5:39. doi: 10.1186/1758-5996-5-39. eCollection 2013.


Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.

Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Review.


Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.


Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice.

Anderson J, Attvall S, Sternemalm L, Pivodic A, Fahlén M, Hanås R, Ekeroth G, Lind M.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1472-9.


Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.

Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ.

Diabetes Technol Ther. 2010 Jul;12(7):507-15. doi: 10.1089/dia.2010.0021.


Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.

Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D.

Am J Manag Care. 2002 Jun;8(6):557-65.


Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.

van Beers CA, DeVries JH, Kleijer SJ, Smits MM, Geelhoed-Duijvestijn PH, Kramer MH, Diamant M, Snoek FJ, Serné EH.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):893-902. doi: 10.1016/S2213-8587(16)30193-0. Epub 2016 Sep 15.


Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.

Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C; DIAMOND Study Group.

J Diabetes Sci Technol. 2017 Apr 1:1932296817704445. doi: 10.1177/1932296817704445. [Epub ahead of print]


Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.


Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV.

Diabetes Care. 2009 Nov;32(11):1947-53. doi: 10.2337/dc09-0889. Epub 2009 Aug 12.


Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.


Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes.

Munshi MN, Segal AR, Slyne C, Samur AA, Brooks KM, Horton ES.

Diabetes Res Clin Pract. 2015 Oct;110(1):60-5. doi: 10.1016/j.diabres.2015.07.012. Epub 2015 Aug 3.


Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S; T1D Exchange Clinic Network.

Diabetes Care. 2014 Oct;37(10):2702-9. doi: 10.2337/dc14-0303. Epub 2014 Jul 10.


Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.

Kesavadev J, Vigersky R, Shin J, Pillai PBS, Shankar A, Sanal G, Krishnan G, Jothydev S.

Adv Ther. 2017 Jun 30. doi: 10.1007/s12325-017-0576-x. [Epub ahead of print]


Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year.

Chamberlain JJ, Dopita D, Gilgen E, Neuman A.

J Diabetes Sci Technol. 2015 Sep 9;10(2):383-8. doi: 10.1177/1932296815604633.

Supplemental Content

Support Center